TreeWAS – Variant ID: rs6871536

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J45.9 Asthma, unspecified	1.000	0.000	0.000
J45 Asthma	0.932	0.068	0.000
J45.0 Predominantly allergic asthma	0.917	0.083	0.000
J45.1 Nonallergic asthma	0.689	0.311	0.000
J45.8 Mixed asthma	0.668	0.332	0.000
J40-J47 Chronic lower respiratory diseases	0.024	0.976	0.000
J44 Other chronic obstructive pulmonary disease	0.019	0.981	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.018	0.982	0.000
J41 Simple and mucopurulent chronic bronchitis	0.017	0.982	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.016	0.984	0.000
J42 Unspecified chronic bronchitis	0.016	0.984	0.000
J43 Emphysema	0.015	0.985	0.000
M16.0 Primary coxarthrosis, bilateral	0.013	0.987	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.013	0.987	0.000
J41.1 Mucopurulent chronic bronchitis	0.013	0.987	0.000
J41.0 Simple chronic bronchitis	0.013	0.987	0.000
J43.8 Other emphysema	0.011	0.989	0.000
C18.9 Colon, unspecified	0.000	0.989	0.011
J46 Status asthmaticus	0.011	0.989	0.000
J43.1 Panlobular emphysema	0.011	0.989	0.000
J43.0 MacLeod's syndrome	0.011	0.989	0.000
J43.2 Centrilobular emphysema	0.010	0.990	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.009	0.991	0.000
J43.9 Emphysema, unspecified	0.007	0.993	0.000
N76.0 Acute vaginitis	0.000	0.993	0.007
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.007	0.993	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.006	0.994	0.000
C18.3 Hepatic flexure	0.000	0.994	0.006
B44.9 Aspergillosis, unspecified	0.005	0.995	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.005	0.995	0.000
C18 Malignant neoplasm of colon	0.000	0.995	0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
G58.8 Other specified mononeuropathies	0.005	0.995	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.005	0.995	0.000
C18.5 Splenic flexure	0.000	0.995	0.005
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.995	0.000
B44 Aspergillosis	0.004	0.996	0.000
C18.8 Overlapping lesion of colon	0.000	0.996	0.004
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
B44.1 Other pulmonary aspergillosis	0.004	0.996	0.000
C18.2 Ascending colon	0.000	0.996	0.004
C54.1 Endometrium	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
C18.6 Descending colon	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
T44.0 Anticholinesterase agents	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
C18.7 Sigmoid colon	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
E23.0 Hypopituitarism	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
T40.2 Other opioids	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
C18.1 Appendix	0.000	0.996	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.996	0.000
B44.8 Other forms of aspergillosis	0.003	0.997	0.000
B44.7 Disseminated aspergillosis	0.003	0.997	0.000
B44.2 Tonsillar aspergillosis	0.003	0.997	0.000
B44.0 Invasive pulmonary aspergillosis	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
N76 Other inflammation of vagina and vulva	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.003	0.997	0.000
J35.0 Chronic tonsillitis	0.003	0.997	0.000
D22 Melanocytic naevi	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
N76.8 Other specified inflammation of vagina and vulva	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
N32.0 Bladder-neck obstruction	0.000	0.997	0.003
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.997	0.003
M16.7 Other secondary coxarthrosis	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
B37.3 Candidiasis of vulva and vagina	0.003	0.997	0.000
E23.2 Diabetes insipidus	0.000	0.997	0.003
L30.9 Dermatitis, unspecified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
C54 Malignant neoplasm of corpus uteri	0.003	0.997	0.000
J40 Bronchitis, not specified as acute or chronic	0.002	0.997	0.001
N76.2 Acute vulvitis	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
T80.2 Infections following infusion, transfusion and therapeutic injection	0.003	0.997	0.000
B35-B49 Mycoses	0.003	0.997	0.000
L30.8 Other specified dermatitis	0.003	0.997	0.000
N76.5 Ulceration of vagina	0.000	0.997	0.003
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.003	0.997	0.000
B37.8 Candidiasis of other sites	0.003	0.997	0.000
K59.8 Other specified functional intestinal disorders	0.000	0.997	0.003
N39.4 Other specified urinary incontinence	0.000	0.997	0.003
N76.3 Subacute and chronic vulvitis	0.000	0.997	0.003
C18.4 Transverse colon	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
H54.7 Unspecified visual loss	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.997	0.000
T42.3 Barbiturates	0.002	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.997	0.000
E23 Hypofunction and other disorders of pituitary gland	0.000	0.997	0.003
T42.1 Iminostilbenes	0.002	0.998	0.000
D22.9 Melanocytic naevi, unspecified	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
B37 Candidiasis	0.002	0.998	0.000
M16 Coxarthrosis [arthrosis of hip]	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
L73.9 Follicular disorder, unspecified	0.002	0.998	0.000
D22.3 Melanocytic naevi of other and unspecified parts of face	0.002	0.998	0.000
C54.8 Overlapping lesion of corpus uteri	0.002	0.998	0.000
C54.3 Fundus uteri	0.002	0.998	0.000
C54.2 Myometrium	0.002	0.998	0.000
C54.0 Isthmus uteri	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
L30 Other dermatitis	0.002	0.998	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.002	0.998	0.000
M43.1 Spondylolisthesis	0.002	0.998	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
B49 Unspecified mycosis	0.002	0.998	0.000
C54.9 Corpus uteri, unspecified	0.002	0.998	0.000
D22.0 Melanocytic naevi of lip	0.002	0.998	0.000
N76.6 Ulceration of vulva	0.000	0.998	0.002
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B47 Mycetoma	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
B36 Other superficial mycoses	0.002	0.998	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.002	0.998	0.000
K83.8 Other specified diseases of biliary tract	0.002	0.998	0.000
H11.0 Pterygium	0.000	0.998	0.002
M16.2 Coxarthrosis resulting from dysplasia, bilateral	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.998	0.002
E23.1 Drug-induced hypopituitarism	0.000	0.998	0.002
N76.1 Subacute and chronic vaginitis	0.000	0.998	0.002
T80 Complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
M88.9 Paget's disease of bone, unspecified	0.002	0.998	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
E23.7 Disorder of pituitary gland, unspecified	0.000	0.998	0.002
H11.3 Conjunctival haemorrhage	0.000	0.998	0.002
Z54.0 Convalescence following surgery	0.000	0.998	0.002
M16.3 Other dysplastic coxarthrosis	0.002	0.998	0.000
B35 Dermatophytosis	0.002	0.998	0.000
K38.1 Appendicular concretions	0.002	0.998	0.000
B37.7 Candidal septicaemia	0.002	0.998	0.000
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
B37.1 Pulmonary candidiasis	0.002	0.998	0.000
M16.6 Other secondary coxarthrosis, bilateral	0.002	0.998	0.000
M16.4 Posttraumatic coxarthrosis, bilateral	0.002	0.998	0.000
Z52.4 Kidney donor	0.002	0.998	0.000
Z96.8 Presence of other specified functional implants	0.002	0.998	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.998	0.002
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.998	0.002
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
H54.0 Blindness, both eyes	0.002	0.998	0.000
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
R50.0 Fever with chills	0.002	0.998	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
L30.3 Infective dermatitis	0.002	0.998	0.000
M43.12 Spondylolisthesis (Cervical region)	0.002	0.998	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.002	0.998	0.000
C18.0 Caecum	0.000	0.998	0.002
L30.5 Pityriasis alba	0.002	0.998	0.000
L30.4 Erythema intertrigo	0.002	0.998	0.000
L30.2 Cutaneous autosensitisation	0.002	0.998	0.000
L30.1 Dyshidrosis [pompholyx]	0.002	0.998	0.000
L30.0 Nummular dermatitis	0.002	0.998	0.000
H11 Other disorders of conjunctiva	0.000	0.998	0.002
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.15 Spondylolisthesis (Thoracolumbar region)	0.002	0.998	0.000
M43.14 Spondylolisthesis (Thoracic region)	0.002	0.998	0.000
M43.13 Spondylolisthesis (Cervicothoracic region)	0.002	0.998	0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.10 Spondylolisthesis (Multiple sites in spine)	0.002	0.998	0.000
J69.0 Pneumonitis due to food and vomit	0.000	0.998	0.002
C55 Malignant neoplasm of uterus, part unspecified	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.998	0.002
B38.9 Coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.002	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.002	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.002	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.002	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.002	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.002	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.002	0.998	0.000
B39.5 Histoplasmosis duboisii	0.002	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.002	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B40.9 Blastomycosis, unspecified	0.002	0.998	0.000
B40.8 Other forms of blastomycosis	0.002	0.998	0.000
B40.7 Disseminated blastomycosis	0.002	0.998	0.000
B40.3 Cutaneous blastomycosis	0.002	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.002	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.002	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.002	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.002	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.002	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.002	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.002	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.002	0.998	0.000
B42.8 Other forms of sporotrichosis	0.002	0.998	0.000
B42.7 Disseminated sporotrichosis	0.002	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.002	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.002	0.998	0.000
B43.9 Chromomycosis, unspecified	0.002	0.998	0.000
B43.8 Other forms of chromomycosis	0.002	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.002	0.998	0.000
B43.1 Phaeomycotic brain abscess	0.002	0.998	0.000
B43.0 Cutaneous chromomycosis	0.002	0.998	0.000
B45.9 Cryptococcosis, unspecified	0.002	0.998	0.000
B45.8 Other forms of cryptococcosis	0.002	0.998	0.000
B45.7 Disseminated cryptococcosis	0.002	0.998	0.000
B45.3 Osseous cryptococcosis	0.002	0.998	0.000
B45.2 Cutaneous cryptococcosis	0.002	0.998	0.000
B45.1 Cerebral cryptococcosis	0.002	0.998	0.000
B45.0 Pulmonary cryptococcosis	0.002	0.998	0.000
B46.9 Zygomycosis, unspecified	0.002	0.998	0.000
B46.8 Other zygomycoses	0.002	0.998	0.000
B46.5 Mucormycosis, unspecified	0.002	0.998	0.000
B46.4 Disseminated mucormycosis	0.002	0.998	0.000
B46.3 Cutaneous mucormycosis	0.002	0.998	0.000
B46.2 Gastro-intestinal mucormycosis	0.002	0.998	0.000
B46.1 Rhinocerebral mucormycosis	0.002	0.998	0.000
B46.0 Pulmonary mucormycosis	0.002	0.998	0.000
B47.9 Mycetoma, unspecified	0.002	0.998	0.000
B47.1 Actinomycetoma	0.002	0.998	0.000
B47.0 Eumycetoma	0.002	0.998	0.000
B48.8 Other specified mycoses	0.002	0.998	0.000
B48.7 Opportunistic mycoses	0.002	0.998	0.000
B48.4 Penicillosis	0.002	0.998	0.000
B48.3 Geotrichosis	0.002	0.998	0.000
B48.2 Allescheriasis	0.002	0.998	0.000
B48.1 Rhinosporidiosis	0.002	0.998	0.000
B48.0 Lobomycosis	0.002	0.998	0.000
C53.9 Cervix uteri, unspecified	0.002	0.998	0.000
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
B36.8 Other specified superficial mycoses	0.002	0.998	0.000
B36.3 Black piedra	0.002	0.998	0.000
B36.2 White piedra	0.002	0.998	0.000
B36.1 Tinea nigra	0.002	0.998	0.000
B36.0 Pityriasis versicolor	0.002	0.998	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.998	0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
G58 Other mononeuropathies	0.002	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.002	0.998	0.000
C51-C58 Malignant neoplasms of female genital organs	0.002	0.998	0.000
G60.0 Hereditary motor and sensory neuropathy	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.002	0.998	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.002	0.998	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.002	0.998	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.002	0.998	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.002	0.998	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.002	0.998	0.000
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
T80.6 Other serum reactions	0.002	0.998	0.000
T80.5 Anaphylactic shock due to serum	0.002	0.998	0.000
T80.4 Rh incompatibility reaction	0.002	0.998	0.000
T80.3 ABO incompatibility reaction	0.002	0.998	0.000
T80.0 Air embolism following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.000	0.998	0.002
Z89.6 Acquired absence of leg above knee	0.000	0.998	0.002
B35.9 Dermatophytosis, unspecified	0.002	0.998	0.000
B35.8 Other dermatophytoses	0.002	0.998	0.000
B35.5 Tinea imbricata	0.002	0.998	0.000
B35.4 Tinea corporis	0.002	0.998	0.000
B35.2 Tinea manuum	0.002	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.998	0.002
J47 Bronchiectasis	0.002	0.998	0.000
M10.99 Gout, unspecified (Site unspecified)	0.002	0.998	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.002	0.998	0.000
C53 Malignant neoplasm of cervix uteri	0.002	0.998	0.000
I28.8 Other specified diseases of pulmonary vessels	0.002	0.998	0.000
B35.1 Tinea unguium	0.002	0.998	0.000
C57.0 Fallopian tube	0.002	0.998	0.000
M16.5 Other posttraumatic coxarthrosis	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.002
H11.1 Conjunctival degenerations and deposits	0.000	0.998	0.002
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.002	0.998	0.000
C52 Malignant neoplasm of vagina	0.002	0.998	0.000
B35.3 Tinea pedis	0.002	0.998	0.000
H54 Blindness and low vision	0.002	0.998	0.000
M19.92 Arthrosis, unspecified (Upper arm)	0.002	0.998	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.998	0.002
B35.6 Tinea cruris	0.001	0.998	0.000
H11.9 Disorder of conjunctiva, unspecified	0.000	0.998	0.002
H11.2 Conjunctival scars	0.000	0.998	0.001
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
D73.4 Cyst of spleen	0.002	0.998	0.000
R50.8 Other specified fever	0.002	0.998	0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.998	0.001
C85.0 Lymphosarcoma	0.000	0.998	0.001
G58.0 Intercostal neuropathy	0.001	0.998	0.000
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
H54.6 Unqualified visual loss, one eye	0.001	0.998	0.000
K63.9 Disease of intestine, unspecified	0.000	0.998	0.002
T17.9 Foreign body in respiratory tract, part unspecified	0.002	0.998	0.000
C51 Malignant neoplasm of vulva	0.001	0.998	0.000
C58 Malignant neoplasm of placenta	0.001	0.998	0.000
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.001	0.998	0.000
D48.1 Connective and other soft tissue	0.000	0.998	0.002
L43.9 Lichen planus, unspecified	0.000	0.998	0.002
B97 Viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.002	0.998	0.000
C57.9 Female genital organ, unspecified	0.001	0.998	0.000
G58.9 Mononeuropathy, unspecified	0.001	0.998	0.000
C53.8 Overlapping lesion of cervix uteri	0.001	0.998	0.000
C53.1 Exocervix	0.001	0.998	0.000
C57.8 Overlapping lesion of female genital organs	0.001	0.998	0.000
C57.7 Other specified female genital organs	0.001	0.998	0.000
C57.4 Uterine adnexa, unspecified	0.001	0.998	0.000
C57.3 Parametrium	0.001	0.998	0.000
C57.2 Round ligament	0.001	0.998	0.000
C57.1 Broad ligament	0.001	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.998	0.001
H54.1 Blindness, one eye, low vision, other eye	0.001	0.998	0.000
Z33 Pregnant state, incidental	0.000	0.998	0.001
H83.0 Labyrinthitis	0.001	0.999	0.000
I05.9 Mitral valve disease, unspecified	0.001	0.999	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.001	0.999	0.000
D48.6 Breast	0.000	0.999	0.001
D73.1 Hypersplenism	0.001	0.999	0.000
H54.3 Unqualified visual loss, both eyes	0.001	0.999	0.000
H54.2 Low vision, both eyes	0.001	0.999	0.000
L94.0 Localised scleroderma [morphea]	0.001	0.999	0.000
Z94.7 Corneal transplant status	0.001	0.999	0.000
D73.5 Infarction of spleen	0.001	0.999	0.000
G58.7 Mononeuritis multiplex	0.001	0.999	0.000
I82.8 Embolism and thrombosis of other specified veins	0.001	0.999	0.000
K38.8 Other specified diseases of appendix	0.001	0.999	0.000
T17.8 Foreign body in other and multiple parts of respiratory tract	0.001	0.999	0.000
T17.5 Foreign body in bronchus	0.001	0.999	0.000
M88.85 Paget's disease of other bones (Pelvic region and thigh)	0.001	0.999	0.000
D73.3 Abscess of spleen	0.001	0.999	0.000
D73 Diseases of spleen	0.001	0.999	0.000
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
B97.5 Reovirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.001	0.999	0.000
C51.9 Vulva, unspecified	0.001	0.999	0.000
C51.8 Overlapping lesion of vulva	0.001	0.999	0.000
C51.2 Clitoris	0.001	0.999	0.000
C51.1 Labium minus	0.001	0.999	0.000
C51.0 Labium majus	0.001	0.999	0.000
D73.8 Other diseases of spleen	0.001	0.999	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.999	0.001
C67.0 Trigone of bladder	0.000	0.999	0.001
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.000	0.999	0.001
C67.8 Overlapping lesion of bladder	0.000	0.999	0.001
C67.6 Ureteric orifice	0.000	0.999	0.001
H01.0 Blepharitis	0.000	0.999	0.001
H54.5 Low vision, one eye	0.001	0.999	0.000
K12.1 Other forms of stomatitis	0.000	0.999	0.001
M88.8 Paget's disease of other bones	0.001	0.999	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.001	0.999	0.000
J99.8 Respiratory disorders in other diseases classified elsewhere	0.001	0.999	0.000
T63.4 Venom of other arthropods	0.000	0.999	0.001
Z94.3 Heart and lungs transplant status	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations